Company Information
CIN
Status
Date of Incorporation
15 March 1994
State / ROC
Mumbai / ROC Mumbai
Last Balance Sheet
31 March 2023
Last Annual Meeting
29 September 2023
Paid Up Capital
48,410,400
Authorised Capital
50,000,000
Directors
Sandeep Verma
Director/Designated Partner
over 2 years ago
over 2 years ago
Kunal Navin Saxena
Director/Designated Partner
over 2 years ago
over 2 years ago
Balasaheb Annasaheb Patil
Director
over 2 years ago
over 2 years ago
Navin Satyapal Saxena
Director/Designated Partner
over 31 years ago
over 31 years ago
Past Directors
Ajay Ramasaran Saxena
Whole Time Director
about 9 years ago
about 9 years ago
Aakarsh Navin Saxena
Director
almost 10 years ago
almost 10 years ago
Naduvil Poduvattil Unnikrishnan
Director
over 12 years ago
over 12 years ago
Patents
The present invention discloses an improved process for the preparation of thebaine from oripavine including the steps of; (a) adding an alkoxide prior to methylation of oripavine solution in inert organic solvent with a suitable methylating agent, (b) extracting the reaction mass in said inert organic solvent and w...
The present invention discloses an improved, simple, efficient, selective process for the preparation of NAL derivatives of formula II, its acid addition salts in high yield and purity from noroxymorphone. The Nal derivatives of formula II are known to possess narcotic agonist/antagonist properties with very low sid...
The invention discloses naltrexone implantable tablets which are devoid of metal salts and corticosteroids, and which provide consistent and controlled amount of naltrexone for 3 months or more; also disclosed is methods of treatment comprising the implants and methods of sterilization of the implants.
...
This invention discloses stable, small volume parenteral dosage form with higher systemic bio-availability and lower toxicity of sodium aminosalicylate. This lyophilized formulation comprises combination of sodium aminosalicylate, polyvinyl pyrrolidone and stabilizers. The formulation is stable at temperature l...
Described herein is a process for the preparation of nalbuphine or its pharmaceutically acceptable salts which is substantially free from the undesirable β- epimer. Also disclosed are the novel intermediates viz N-ethoxycarbonyl- 10-acetoxynorcodeinone (III), N-ethoxycarbonyl 14-acetoxynorcodeine(lV), N-ethoxy carbo...
Disclosed herein is a process for the preparation of 4,5 α-epoxy-3,14-dihydroxynormorphinan-7-ene-6-one (Formula V) including the steps of; (i) N-demethylating 4,5 a-epoxy-3,34-diacetoxy-17-methyl morphinan-7-ene-6-one of Formula III to form N-ethoxycarbonyl-4,5 a-epoxy-3,14-diacetoxy normorphinan-7-ene-6-one of For...
The present invention discloses an efficient industrial process for the preparation of 21-cyclopropyl-7a-(2-hydroxy-3,3-dimethyl-2-butyl)-6,14-endo-ethano-6,7,8,14-tetrahydro-oripavine, i.e Buprenorphine of Formula-I in high yield and purity, with enhanced safety and eco-friendly norms. The invention further relates...
The present invention discloses a short, simplified and eco-friendly process for producing Nalbuphine or its pharmaceutically acceptable salts thereof. In particular, the process of the present invention avoids use of any hazardous, corrosive and pyrophoric chemicals and the product formed is substantially free of i...
Registered Trademarks
[Class : 5] Patches Containing Pharmaceutical Preparations; Transdermal Patches Containing Pharmaceutical Preparations; Adhesive Patches For Surgical Use; Adhesive Patches For Medical Use; Transdermal Patches For Administering Pharmaceuticals; Adhesive Patches Containing Pharmaceutical Preparations; Vitamin Supplement Patches; Transdermal Patches For Medical Treatment; Adhes...
[Class : 5] Pharmaceutical, Medicinal And Ayurvedic Preparations And Substances; Dietetic Food And Substances Adapted For Medical Use, Dietary Supplements For Humans; Nutritional Supplements; Nutraceutical Preparations For Therapeutic Or Medical Purposes; Nutraceuticals For Use As Dietary Supplements
[Class : 5] Pharmaceutical, Medicinal And Ayurvedic Preparations And Substances; Dietetic Food And Substances Adapted For Medical Use, Dietary Supplements For Humans; Nutritional Supplements; Nutraceutical Preparations For Therapeutic Or Medical Purposes; Nutraceuticals For Use As Dietary Supplements
View +97 more Brands for Rusan Pharma Limited.
Charges
16 April 2018
Canara Bank
6 Crore
28 June 2016
Syndicate Bank
3 Crore
28 December 2015
Icici Bank Limited
7 Crore
19 February 2010
State Bank Of India
9 Lak
05 August 2007
State Bank Of India
8 Crore
17 October 2005
State Bank Of India
30 Crore
20 September 1994
Canara Bank
66 Crore
06 December 2001
Canara Bank
69 Crore
31 August 2021
Canara Bank
75 Crore
29 September 2020
Canara Bank
16 Crore
23 May 2020
Icici Bank Limited
16 Crore
16 December 2022
Others
0
27 July 2022
Others
0
20 September 1994
Canara Bank
0
31 August 2021
Canara Bank
0
20 July 2020
Canara Bank
0
23 May 2020
Others
0
28 December 2015
Others
0
16 April 2018
Canara Bank
0
17 October 2005
State Bank Of India
0
29 September 2020
Canara Bank
0
06 December 2001
Canara Bank
0
05 August 2007
State Bank Of India
0
28 June 2016
Syndicate Bank
0
19 February 2010
State Bank Of India
0
16 December 2022
Others
0
27 July 2022
Others
0
20 September 1994
Canara Bank
0
31 August 2021
Canara Bank
0
20 July 2020
Canara Bank
0
23 May 2020
Others
0
28 December 2015
Others
0
16 April 2018
Canara Bank
0
17 October 2005
State Bank Of India
0
29 September 2020
Canara Bank
0
06 December 2001
Canara Bank
0
05 August 2007
State Bank Of India
0
28 June 2016
Syndicate Bank
0
19 February 2010
State Bank Of India
0
16 December 2022
Others
0
27 July 2022
Others
0
20 September 1994
Canara Bank
0
31 August 2021
Canara Bank
0
20 July 2020
Canara Bank
0
23 May 2020
Others
0
28 December 2015
Others
0
16 April 2018
Canara Bank
0
17 October 2005
State Bank Of India
0
29 September 2020
Canara Bank
0
06 December 2001
Canara Bank
0
05 August 2007
State Bank Of India
0
28 June 2016
Syndicate Bank
0
19 February 2010
State Bank Of India
0
